83 related articles for article (PubMed ID: 26908450)
1. Serum protein profiling using an aptamer array predicts clinical outcomes of stage IIA colon cancer: A leave-one-out crossvalidation.
Huh JW; Kim SC; Sohn I; Jung SH; Kim HC
Oncotarget; 2016 Mar; 7(13):16338-48. PubMed ID: 26908450
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact of elastic laminal invasion in colon cancer: elastic laminal invasion-positive stage II colon cancer is a high-risk equivalent to stage III.
Yokota M; Kojima M; Nomura S; Nishizawa Y; Kobayashi A; Ito M; Ochiai A; Saito N
Dis Colon Rectum; 2014 Jul; 57(7):830-8. PubMed ID: 24901683
[TBL] [Abstract][Full Text] [Related]
3. Tumour budding is a reproducible index for risk stratification of patients with stage II colon cancer.
Lai YH; Wu LC; Li PS; Wu WH; Yang SB; Xia P; He XX; Xiao LB
Colorectal Dis; 2014 Apr; 16(4):259-64. PubMed ID: 24118729
[TBL] [Abstract][Full Text] [Related]
4. Association of Mixed Lineage Kinase Domain-Like Protein Expression With Prognosis in Patients With Colon Cancer.
Li X; Guo J; Ding AP; Qi WW; Zhang PH; Lv J; Qiu WS; Sun ZQ
Technol Cancer Res Treat; 2017 Aug; 16(4):428-434. PubMed ID: 27432118
[TBL] [Abstract][Full Text] [Related]
5. Preoperative serum markers for individual patient prognosis in stage I-III colon cancer.
Giessen-Jung C; Nagel D; Glas M; Spelsberg F; Lau-Werner U; Modest DP; Schulz C; Heinemann V; Di Gioia D; Stieber P
Tumour Biol; 2015 Sep; 36(10):7897-906. PubMed ID: 25953265
[TBL] [Abstract][Full Text] [Related]
6. Colon cancer with unresectable synchronous metastases: the AAAP scoring system for predicting the outcome after primary tumour resection.
Li ZM; Peng YF; Du CZ; Gu J
Colorectal Dis; 2016 Mar; 18(3):255-63. PubMed ID: 26400111
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.
Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY
Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Molecular Detection of Lymph Node Metastases After Curative Resection of Stage II Colon Cancer: A Systematic Pooled Data Analysis.
Gill S; Haince JF; Shi Q; Pavey ES; Beaudry G; Sargent DJ; Fradet Y
Clin Colorectal Cancer; 2015 Jun; 14(2):99-105. PubMed ID: 25619805
[TBL] [Abstract][Full Text] [Related]
9. Validation of the 12-gene colon cancer recurrence score as a predictor of recurrence risk in stage II and III rectal cancer patients.
Reimers MS; Kuppen PJ; Lee M; Lopatin M; Tezcan H; Putter H; Clark-Langone K; Liefers GJ; Shak S; van de Velde CJ
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25261968
[TBL] [Abstract][Full Text] [Related]
10. p66 Shc tumor levels show a strong prognostic correlation with disease outcome in stage IIA colon cancer.
Grossman SR; Lyle S; Resnick MB; Sabo E; Lis RT; Rosinha E; Liu Q; Hsieh CC; Bhat G; Frackelton AR; Hafer LJ
Clin Cancer Res; 2007 Oct; 13(19):5798-804. PubMed ID: 17908971
[TBL] [Abstract][Full Text] [Related]
11. High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer.
Park JS; Chon HJ; Jeung HC; Shin SJ; Rha SY; Ahn JB; Lee KY; Kim NK; Chung HC
J Cancer Res Clin Oncol; 2016 Sep; 142(9):2051-9. PubMed ID: 27447697
[TBL] [Abstract][Full Text] [Related]
12. Preoperative carcinoembryonic antigen level as an independent prognostic factor in potentially curative colon cancer.
Huh JW; Oh BR; Kim HR; Kim YJ
J Surg Oncol; 2010 Apr; 101(5):396-400. PubMed ID: 20119979
[TBL] [Abstract][Full Text] [Related]
13. Screening of specific nucleic acid aptamers binding tumor markers in the serum of the lung cancer patients and identification of their activities.
Li K; Xiu CL; Gao LM; Liang HG; Xu SF; Shi M; Li J; Liu ZW
Tumour Biol; 2017 Jul; 39(7):1010428317717123. PubMed ID: 28718373
[TBL] [Abstract][Full Text] [Related]
14. Test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data.
Di Narzo AF; Tejpar S; Rossi S; Yan P; Popovici V; Wirapati P; Budinska E; Xie T; Estrella H; Pavlicek A; Mao M; Martin E; Scott W; Bosman FT; Roth A; Delorenzi M
J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25246611
[TBL] [Abstract][Full Text] [Related]
15. A scoring system based on artificial neural network for predicting 10-year survival in stage II A colon cancer patients after radical surgery.
Peng JH; Fang YJ; Li CX; Ou QJ; Jiang W; Lu SX; Lu ZH; Li PX; Yun JP; Zhang RX; Pan ZZ; Wan de S
Oncotarget; 2016 Apr; 7(16):22939-47. PubMed ID: 27008710
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum levels of MMP-11 correlate with poor prognosis in colon cancer patients.
Pang L; Wang DW; Zhang N; Xu DH; Meng XW
Cancer Biomark; 2016 Mar; 16(4):599-607. PubMed ID: 27002762
[TBL] [Abstract][Full Text] [Related]
17. Expression of interleukine-8 as an independent prognostic factor for sporadic colon cancer dissemination.
Nastase A; Paslaru L; Herlea V; Ionescu M; Tomescu D; Bacalbasa N; Dima S; Popescu I
J Med Life; 2014 Jun; 7(2):215-9. PubMed ID: 25408728
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of perineural invasion in stage IIA colon cancer.
Yun JA; Kim HC; Kim SH; Cho YB; Yun SH; Lee WY; Chun HK
ANZ J Surg; 2016 Dec; 86(12):1007-1013. PubMed ID: 25113398
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of microRNA-93 downregulation in human colon cancer.
Xiao ZG; Deng ZS; Zhang YD; Zhang Y; Huang ZC
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):296-301. PubMed ID: 23354160
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy increase survival and decrease recurrence in stage IIA colon cancer.
Yun HR; Kim HC; Yun SH; Lee WY
Hepatogastroenterology; 2012; 59(120):2466-71. PubMed ID: 23169179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
